Indonesia resumes the usage of the temporarily suspended batch of the Oxford–AstraZeneca COVID-19 vaccine
Indonesia resumes the usage of the temporarily suspended batch of the Oxford–AstraZeneca COVID-19 vaccine after tests conducted by the Food and Drug Authority showed that there is no relation between the quality of vaccine batch number CTMAV547 and the death of a young man earlier in the month.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthIndonesia resumes the usage of the temporarily suspended batch of the Oxford–AstraZeneca COVID-19 vaccine
View Premium plansBrowse free archive reportsIndonesia resumes the usage of the temporarily suspended batch of the Oxford–AstraZeneca COVID-19 vaccine after tests conducted by the Food and Drug Authority showed that there is no relation between the quality of vaccine batch number CTMAV547 and the death of a young man earlier in the month.